cagrilintide semaglutide combination phase 3 2024 Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, study Novo Nordisk's stock drops despite

Start by washing your hands, and end by throwing away the used items the right way

May 2026: 13 more lawsuits have been added to the federal NAION MDL against Novo Nordisk (Rybelsus) and other GLP-1 companies, bringing the total to 86

In 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg pens there are 4 doses , which means each pen will last for 4 weeks of treatment, as long as youre taking 1 injection a week

This practice gives patients more time to adapt to a healthy lifestyle

When made in compounding pharmacies that use less rigorous stability testing or rely on external data to determine stability, the BUD will be shorter, generally 1428 days , to make sure it stays safe and effective